Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. In 2001, he joined Astex Pharmaceuticals in Cambridge where he became an expert in fragment-based drug discovery working on diabetes, thrombotic and oncology drug targets.
Let's personalize your content